skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: An Engineered Disulfide Bond Reversibly Traps the IgE-Fc3-4 in a Closed, Nonreceptor Binding Conformation

Journal Article · · Journal of Biological Chemistry

IgE antibodies interact with the high affinity IgE Fc receptor, FcϵRI, and activate inflammatory pathways associated with the allergic response. The IgE-Fc region, comprising the C-terminal domains of the IgE heavy chain, binds FcϵRI and can adopt different conformations ranging from a closed form incompatible with receptor binding to an open, receptor-bound state. A number of intermediate states are also observed in different IgE-Fc crystal forms. To further explore this apparent IgE-Fc conformational flexibility and to potentially trap a closed, inactive state, we generated a series of disulfide bond mutants. Here we describe the structure and biochemical properties of an IgE-Fc mutant that is trapped in the closed, non-receptor binding state via an engineered disulfide at residue 335 (Cys-335). Reduction of the disulfide at Cys-335 restores the ability of IgE-Fc to bind to its high affinity receptor, FcϵRIα. The structure of the Cys-335 mutant shows that its conformation is within the range of previously observed, closed form IgE-Fc structures and that it retains the hydrophobic pocket found in the hinge region of the closed conformation. Locking the IgE-Fc into the closed state with the Cys-335 mutation does not affect binding of two other IgE-Fc ligands, omalizumab and DARPin E2_79, demonstrating selective blocking of the high affinity receptor binding.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
OTHERNIH
OSTI ID:
1087769
Journal Information:
Journal of Biological Chemistry, Vol. 287, Issue (43) ; 10, 2012; ISSN 0021-9258
Publisher:
American Society for Biochemistry and Molecular Biology
Country of Publication:
United States
Language:
ENGLISH

Similar Records

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
Journal Article · Thu May 19 00:00:00 EDT 2016 · Nature Communications · OSTI ID:1087769

The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab
Journal Article · Wed Jan 08 00:00:00 EST 2020 · Nature Communications · OSTI ID:1087769

The Analysis of the Human High Affinity IgE Receptor FceRIa from Multiple Crystal Forms
Journal Article · Fri Mar 05 00:00:00 EST 2010 · J. Mol. Biol. · OSTI ID:1087769

Related Subjects